NYSE:PFE - Pfizer Stock Price, Forecast & News

Pfizer trades on the New York Stock Exchange (NYSE) under the ticker symbol "PFE."

Pfizer announced a quarterly dividend on Monday, December 16th. Investors of record on Friday, January 31st will be given a dividend of $0.38 per share on Friday, March 6th. This represents a $1.52 dividend on an annualized basis and a yield of 3.75%. The ex-dividend date of this dividend is Thursday, January 30th. This is a boost from Pfizer's previous quarterly dividend of $0.36. View Pfizer's Dividend History.

Pfizer declared that its board has authorized a stock buyback program on Friday, December 14th 2018, which permits the company to buyback $10,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to buy up to 3.8% of its stock through open market purchases. Stock buyback programs are typically a sign that the company's board of directors believes its stock is undervalued.

Pfizer Inc. (NYSE:PFE) announced its quarterly earnings results on Tuesday, October, 29th. The biopharmaceutical company reported $0.75 EPS for the quarter, topping the Zacks' consensus estimate of $0.62 by $0.13. The biopharmaceutical company earned $12.68 billion during the quarter, compared to the consensus estimate of $12.37 billion. Pfizer had a return on equity of 28.10% and a net margin of 30.57%. The business's revenue was down 4.6% compared to the same quarter last year. During the same period in the previous year, the business posted $0.78 EPS. View Pfizer's Earnings History.

Pfizer is scheduled to release their next quarterly earnings announcement on Tuesday, January 28th 2020. View Earnings Estimates for Pfizer.

Pfizer will be holding an earnings conference call on Tuesday, January 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Pfizer updated its FY19 earnings guidance on Tuesday, October, 29th. The company provided earnings per share guidance of $2.94-3.00 for the period, compared to the Thomson Reuters consensus estimate of $2.82. The company issued revenue guidance of $51.2-52.2 billion, compared to the consensus revenue estimate of $51.47 billion.

12 analysts have issued 12 month price targets for Pfizer's stock. Their forecasts range from $36.00 to $55.00. On average, they anticipate Pfizer's share price to reach $43.86 in the next year. This suggests a possible upside of 8.3% from the stock's current price. View Analyst Price Targets for Pfizer.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pfizer in the last year. There are currently 8 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Pfizer.

Media coverage about PFE stock has trended positive this week, according to InfoTrie Sentiment. The research group rates the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Pfizer earned a news sentiment score of 3.0 on InfoTrie's scale. They also assigned news articles about the biopharmaceutical company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the next several days. View News Stories for Pfizer.

Some companies that are related to Pfizer include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Eli Lilly And Co (LLY), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Allergan (AGN), Mylan (MYL), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Horizon Therapeutics (HZNP), The Medicines (MDCO), Nektar Therapeutics (NKTR), Zogenix (ZGNX) and Pacira Biosciences (PCRX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Pfizer investors own include AT&T (T), Cisco Systems (CSCO), Verizon Communications (VZ), Johnson & Johnson (JNJ), Intel (INTC), General Electric (GE), Bank of America (BAC), Exxon Mobil (XOM), AbbVie (ABBV) and Walt Disney (DIS).

Pfizer's stock is owned by many different of institutional and retail investors. Top institutional shareholders include PGGM Investments (0.07%), Calamos Advisors LLC (0.06%), DNB Asset Management AS (0.06%), Gateway Investment Advisers LLC (0.04%), Nisa Investment Advisors LLC (0.04%) and Hexavest Inc. (0.04%). Company insiders that own Pfizer stock include Alexander R Mackenzie, Charles H Hill, Dawn Rogers, Douglas M Lankler, Frank A Damelio, Ian C Read, Kirsten Lund-Jurgensen, Laurie J Olson, Loretta V Cangialosi, Mikael Dolsten, Pfizer Inc, Rady A Johnson, Sally Susman, Scott Gottlieb and W Don Cornwell. View Institutional Ownership Trends for Pfizer.

PFE stock was sold by a variety of institutional investors in the last quarter, including PGGM Investments, Artemis Investment Management LLP, Hexavest Inc., DNB Asset Management AS, State of Alaska Department of Revenue, Gateway Investment Advisers LLC, Huntington National Bank and Nisa Investment Advisors LLC. Company insiders that have sold Pfizer company stock in the last year include Alexander R Mackenzie, Dawn Rogers, Douglas M Lankler, Frank A Damelio, Mikael Dolsten and Rady A Johnson. View Insider Buying and Selling for Pfizer.

PFE stock was purchased by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, New England Professional Planning Group Inc., Johanson Financial Advisors Inc., Donaldson Capital Management LLC, Calamos Advisors LLC, Corbenic Partners LLC, Manning & Napier Group LLC and Pennsylvania Trust Co. Company insiders that have bought Pfizer stock in the last two years include Pfizer Inc and Scott Gottlieb. View Insider Buying and Selling for Pfizer.

Shares of PFE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of PFE stock can currently be purchased for approximately $40.50.

Pfizer has a market capitalization of $224.13 billion and generates $53.65 billion in revenue each year. The biopharmaceutical company earns $11.15 billion in net income (profit) each year or $3.00 on an earnings per share basis. Pfizer employs 92,400 workers across the globe.View Additional Information About Pfizer.

The official website for Pfizer is http://www.pfizer.com/.

Pfizer's mailing address is 235 EAST 42ND STREET, NEW YORK NY, 10017. The biopharmaceutical company can be reached via phone at 212-733-2323.